2020
DOI: 10.7759/cureus.8342
|View full text |Cite
|
Sign up to set email alerts
|

Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials

Abstract: Bhagavathula et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
43
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(44 citation statements)
references
References 40 publications
1
43
0
Order By: Relevance
“…Further, colleges in the United States cost more than higher education institutions nearly anywhere else in the world [ 24 ]; therefore, financial concerns may be particularly apparent in the United States. The United States also experienced the lowest global recovery rate from infection–in other words, the highest mortality rate post-infection–in the weeks leading up to the timing of the current study (April and May, 2020) [ 25 ]. This country continues to witness the highest incidence and mortality rates among Global North countries [ 26 ].…”
Section: Introductionmentioning
confidence: 99%
“…Further, colleges in the United States cost more than higher education institutions nearly anywhere else in the world [ 24 ]; therefore, financial concerns may be particularly apparent in the United States. The United States also experienced the lowest global recovery rate from infection–in other words, the highest mortality rate post-infection–in the weeks leading up to the timing of the current study (April and May, 2020) [ 25 ]. This country continues to witness the highest incidence and mortality rates among Global North countries [ 26 ].…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, cytotoxic T lymphocytes (CTLs) will be activated by LV-DC presenting COVID-19 specific antigens. Healthy and COVID-19 positive subjects will receive LV-DC vaccine and antigen-specific CTLs and safety, as well as clinical improvement, lung injury, mortality, duration of mechanical ventilation, among other parameters, will be determined for this vaccine [175,176]. Results regarding are estimated to be available by 2024 [175].…”
Section: Modulation Of Dendritic Cell As Prospects For the Treatmentmentioning
confidence: 99%
“…Short-term, reactive virology-based measures (e.g., quarantines, repurposed drugs, etc.) are required to contain the present SARS-CoV-2 outbreak ( Farsalinos et al, 2020 ; Nitulescu et al, 2020 ; Zhang et al, 2020 ; Bhagavathula et al, 2020 ; Skalny et al, 2020 ; Torequl Islam et al, 2020 ). However, the long-term, proactive toxicology-based measures required to intrinsically strengthen the immune system and prevent such future outbreaks have not been addressed.…”
Section: Role Of Sars-cov-2 In Emergence Of Covid-19mentioning
confidence: 99%